Non-small cell lung cancer therapy: safety and efficacy in the elderly

被引：15

作者：

Glotzer, Owen S. ^{[1
]}

Fabian, Thomas ^{[1
]}

Chandra, Anurag ^{[2
]}

Bakhos, Charles T. ^{[2
]}

机构：

[1] Albany Med Coll, Albany Med Ctr, Dept Surg, Div Thorac Surg, 50 New Scotland Ave, Albany, NY 12208 USA

[2] Albany Med Coll, Albany Med Ctr, Dept Radiat Oncol, Albany, NY 12208 USA

来源：

DRUG HEALTHCARE AND PATIENT SAFETY | 2013年 / 5卷

关键词：

thoracic surgery; radiation therapy; chemotherapy; pulmonary; physiology; ageing; SBRT;

D O I：

10.2147/DHPS.S41199

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Background: Our objective was to evaluate and review the current literature on the treatment of non-small cell lung cancer (NSCLC) in the elderly. Methods: We selected recent peer-reviewed articles addressing ageing, cancer treatment in the elderly, and lung cancer treatment in the elderly. We defined elderly as over the age of 70. Results: The population is ageing dramatically throughout most of the world. Given that situation, clinicians are seeing and being asked to treat more elderly patients that have NSCLC. Elderly patients are less likely to participate or be allowed to participate in prospective or retrospective studies of treatments for NSCLC. Elderly patients are also less likely to be staged appropriately for their advanced tumors, and are less likely to be referred for surgery or adjuvant therapy after surgery. When treatment is tailored to patient comorbidities but not to age, the data support survival and outcomes comparable to those of younger patients. Conclusions: Data are limited on the treatment of elderly patients with NSCLC. No data exist to support limiting recommendations for treatment based on age alone. Treatments should be determined on an individual basis.

引用

页码：113 / 121

页数：9

共 70 条

[1]

Global Cancer Research Programs, (2012)

[2]

Surveillance Epidemiology and End Results, (2012)

[3]

Population Ageing and Development, (2009)

[4]

Commerce USDo. United States 2010 Census, (2010)

[5]

Arias E., United States life tables, 2007. National vital statistics reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 59, 9, pp. 1-60, (2011)

[6]

Leonard R.C., Barrett-Lee P.J., Gosney M.A., Willett A.M., Reed M.W., Hammond P.J., Effect of patient age on management decisions in breast cancer: Consensus from a national consultation, The oncologist., 15, 7, pp. 657-664, (2010)

[7]

Kassam F., Shepherd F.A., Johnston M., Et al., Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer, Journal of thoracic oncology: Official publication of the International Association for the Study of Lung Cancer, 2, 1, pp. 39-43, (2007)

[8]

Kang K.M., Jeong B.K., Ha I.B., Et al., Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer, Radiation oncology journal, 30, 3, pp. 140-145, (2012)

[9]

Guckenberger M., Kavanagh A., Partridge M., Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer, Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft, 188, 10, pp. 894-900, (2012)

[10]

Suda K., Tomizawa K., Mizuuchi H., Et al., Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts, Aging and disease, 3, 6, pp. 438-443, (2012)

← 1 2 3 4 5 6 7 →